Article

Medicare administrator Scully to step down

Tom Scully, administrator of the Centers for Medicare & Medicaid Services, will resign effective Dec. 15, following 3 years at the helm of two of the nation's largest domestic programs.

Related Videos
1 expert in this video
1 expert is featured in this series.
1 expert is featured in this series.
Anna Myers, CNP, answers a question during a Zoom video interview
Related Content
Skyler Howell, MD | Credit: X.com
April 28th 2025

AUA 2025: GLP-1 RAs could improve sperm count in overweight men

Patrick Campbell
New research reveals GLP-1 receptor agonists may enhance sperm counts in overweight men.
Pearls & Perspectives: Urology's Role in GLP-1 RA Treatments, with Hossein Sadeghi-Nejad, MD, and Nathalie Eid, BA | Credit: Urology Times
April 28th 2025

Pearls & Perspectives: Urology's role in GLP-1 RA treatments, with Hossein Sadeghi-Nejad, MD, and Nathalie Eid, BA

Amy M. Pearlman, MD Hossein Sadeghi-Nejad, MD Nathalie Eid, BA
This episodes explores the evolving role of GLP-1 medications in testosterone management and their impact on male sexual health and fertility.
Stephen J. Freedland, MD
April 28th 2025

Most men in EMBARK trial recover T levels following treatment suspension

Benjamin P. Saylor
More than 80% of patients in both groups had a full recovery of testosterone.
Pearls & Perspectives: Updates in testosterone therapy, with Andrew Sun, MD at AUA 2025
April 27th 2025

Pearls & Perspectives: Updates in testosterone therapy, with Andrew Sun, MD at AUA 2025

Amy M. Pearlman, MD Andrew Y. Sun, MD
Andrew Sun, MD, joins Pearls & Perspectives to discuss innovative approaches to testosterone therapy for enhanced health outcomes.
Du Geon Moon, MD, PhD | Credit: Korea University College of Medicine
April 27th 2025

Sildenafil/Clomipramine Combo Boosts Outcomes in Premature Ejaculation

Patrick Campbell
A phase 3 trial reveals a combination therapy for premature ejaculation significantly enhances treatment outcomes.
Blur image of hospital corridor | Image Credit: © jakkapan - stock.adobe.com
April 27th 2025

Estimated DOR of 2 years is seen with UGN-102 in LG-IR-NMIBC

Benjamin P. Saylor
The investigators reported that the median Kaplan-Meier estimate of DOR was 24.2 months.
© 2025 MJH Life Sciences

All rights reserved.